Literature DB >> 22201853

Peritoneal endometriosis is an inflammatory disease.

Jean-Christophe Lousse1, Anne Van Langendonckt, Sylvie Defrere, Reinaldo Gonzalez Ramos, Sebastien Colette, Jacques Donnez.   

Abstract

Peritoneal endometriosis is a chronic inflammatory disease characterized by increased numbers of peritoneal macrophages and their secreted products. Inflammation plays a major role in pain and infertility associated with endometriosis, but is also extensively involved in the molecular processes that lead to peritoneal lesion development. Peritoneal oxidative stress is currently thought to be a major constituent of the endometriosis-associated inflammatory response. Excessive production of reactive oxygen species, secondary to peritoneal influx of pro-oxidants such as heme and iron during retrograde menstruation, may induce cellular damage and increased proinflammatory gene expression through nuclear factor-kappa B activation. In particular, prostaglandin biosynthetic enzyme expression is regulated by this transcriptional factor, and increased peritoneal prostaglandin concentrations have been demonstrated in endometriosis. In the light of available data collected from patient biopsies, as well as in vitro and in vivo studies, the respective involvement and potential molecular interactions of iron, nuclear factor-kappa B and prostaglandins in the pathogenesis of endometriosis are explored and discussed. The key role of peritoneal macrophages is emphasized and potential therapeutic targets are examined.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201853     DOI: 10.2741/e358

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  33 in total

1.  Immune-inflammation gene signatures in endometriosis patients.

Authors:  Soo Hyun Ahn; Kasra Khalaj; Steven L Young; Bruce A Lessey; Madhuri Koti; Chandrakant Tayade
Journal:  Fertil Steril       Date:  2016-07-27       Impact factor: 7.329

2.  Association of the Precursor of Interleukin-1β and Peritoneal Inflammation-Role in Pathogenesis of Endometriosis.

Authors:  Justyna Sikora; Aleksandra Mielczarek-Palacz; Zdzisława Kondera-Anasz
Journal:  J Clin Lab Anal       Date:  2016-03-28       Impact factor: 2.352

3.  Berberine inhibits the LPS-induced proliferation and inflammatory response of stromal cells of adenomyosis tissues mediated by the LPS/TLR4 signaling pathway.

Authors:  Li Liu; Li Chen; Caixia Jiang; Jing Guo; Yan Xie; Le Kang; Zhongping Cheng
Journal:  Exp Ther Med       Date:  2017-10-16       Impact factor: 2.447

4.  A prospective cohort study of meat and fish consumption and endometriosis risk.

Authors:  Ayae Yamamoto; Holly R Harris; Allison F Vitonis; Jorge E Chavarro; Stacey A Missmer
Journal:  Am J Obstet Gynecol       Date:  2018-06-02       Impact factor: 8.661

5.  Prostaglandin levels, vaginal innervation, and cyst innervation as peripheral contributors to endometriosis-associated vaginal hyperalgesia in rodents.

Authors:  Stacy L McAllister; Barbra K Giourgas; Elizabeth K Faircloth; Emma Leishman; Heather B Bradshaw; Eric R Gross
Journal:  Mol Cell Endocrinol       Date:  2016-08-11       Impact factor: 4.102

6.  Defining future directions for endometriosis research: workshop report from the 2011 World Congress of Endometriosis In Montpellier, France.

Authors:  Peter A W Rogers; Thomas M D'Hooghe; Asgerally Fazleabas; Linda C Giudice; Grant W Montgomery; Felice Petraglia; Robert N Taylor
Journal:  Reprod Sci       Date:  2013-02-20       Impact factor: 3.060

Review 7.  The role of lipoxin A4 in endometrial biology and endometriosis.

Authors:  G O Canny; B A Lessey
Journal:  Mucosal Immunol       Date:  2013-03-13       Impact factor: 7.313

8.  Endometriosis, a disease of the macrophage.

Authors:  Annalisa Capobianco; Patrizia Rovere-Querini
Journal:  Front Immunol       Date:  2013-01-28       Impact factor: 7.561

Review 9.  Can Endometriosis-Related Oxidative Stress Pave the Way for New Treatment Targets?

Authors:  Luciana Cacciottola; Jacques Donnez; Marie-Madeleine Dolmans
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

Review 10.  PPARγ Agonists: Emergent Therapy in Endometriosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Alain Le Blanche; Yves Lecarpentier
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.